Investor insights
Sectors invested in
Biotechnology1
alcohol use disorder1
clinical trials1
Pharmaceutical1
psilocybin therapy1
drug development1
Therapeutics1
psychedelic research1
Funding rounds participated in
$2M sweet spot round size
Most of their 2 investments are in rounds between $2M and $2M
Investor type
Venture Capital
Basic info
Industry
financial services
Sectors
Date founded
2020
Investments made
C
Clairvoyant Therapeutics Inc. raised undisclosed on July 7, 2022
Investors: Origin Therapeutics
U
Undisclosed raised $2M on June 1, 2021
Investors: Ocama Partners, Vine Ventures, Masnavi Capital Real Estate, Receptor Partners, LLC, Palo Santo, K50 Ventures, The Cannabis Fund, Negev Capital and Origin Therapeutics